BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33843820)

  • 1. Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.
    Rocha JM; Rossi GN; de Lima Osório F; Bouso JC; de Oliveira Silveira G; Yonamine M; Campos AC; Bertozi G; Cecílio Hallak JE; Dos Santos RG
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):267-274. PubMed ID: 33843820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial.
    Dos Santos RG; Osório FL; Rocha JM; Rossi GN; Bouso JC; Rodrigues LS; de Oliveira Silveira G; Yonamine M; Hallak JEC
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):540-550. PubMed ID: 34166299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers: A Pilot, Proof-of-Concept, Feasibility, Randomized-Controlled Trial.
    Rossi GN; Rocha JM; Osório FL; Bouso JC; Ona G; Silveira GO; Yonamine M; Bertozi G; Crevelin EJ; Queiroz ME; Crippa JAS; Hallak JEC; Dos Santos RG
    J Clin Psychopharmacol; 2023 Jul-Aug 01; 43(4):339-349. PubMed ID: 37335211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.
    Rocha JM; Osório FL; Crippa JAS; Bouso JC; Rossi GN; Hallak JEC; Dos Santos RG
    Ther Adv Psychopharmacol; 2019; 9():2045125319845774. PubMed ID: 31065350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trials.
    Dos Santos RG; Rocha JM; Rossi GN; Osório FL; Ona G; Bouso JC; Silveira GO; Yonamine M; Marchioni C; Crevelin EJ; Queiroz ME; Crippa JA; Hallak JEC
    Hum Psychopharmacol; 2022 Jul; 37(4):e2834. PubMed ID: 35107855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use: A Single-blind, Feasibility, Proof-of-Concept Trial.
    Rodrigues LS; Reis JAS; Rossi GN; Guerra LTL; Maekawa RM; de Lima Osório F; Bouso JC; Santos FP; Paranhos BAPB; Yonamine M; Hallak JEC; Dos Santos RG
    J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):402-406. PubMed ID: 38820373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study.
    Sanches RF; de Lima Osório F; Dos Santos RG; Macedo LR; Maia-de-Oliveira JP; Wichert-Ana L; de Araujo DB; Riba J; Crippa JA; Hallak JE
    J Clin Psychopharmacol; 2016 Feb; 36(1):77-81. PubMed ID: 26650973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.
    Riba J; Anderer P; Morte A; Urbano G; Jané F; Saletu B; Barbanoj MJ
    Br J Clin Pharmacol; 2002 Jun; 53(6):613-28. PubMed ID: 12047486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
    Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
    J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of ayahuasca administered in two repeated doses.
    Dos Santos RG; Grasa E; Valle M; Ballester MR; Bouso JC; Nomdedéu JF; Homs R; Barbanoj MJ; Riba J
    Psychopharmacology (Berl); 2012 Feb; 219(4):1039-53. PubMed ID: 21842159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.
    Dos Santos RG; Bouso JC; Alcázar-Córcoles MÁ; Hallak JEC
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):889-902. PubMed ID: 30102078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.
    Riba J; Romero S; Grasa E; Mena E; Carrió I; Barbanoj MJ
    Psychopharmacology (Berl); 2006 May; 186(1):93-8. PubMed ID: 16575552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.
    Riba J; Valle M; Urbano G; Yritia M; Morte A; Barbanoj MJ
    J Pharmacol Exp Ther; 2003 Jul; 306(1):73-83. PubMed ID: 12660312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
    Valle M; Maqueda AE; Rabella M; Rodríguez-Pujadas A; Antonijoan RM; Romero S; Alonso JF; Mañanas MÀ; Barker S; Friedlander P; Feilding A; Riba J
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1161-75. PubMed ID: 27039035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.
    Mendes Rocha J; Rossi GN; Osório FL; Bouso Saiz JC; Silveira GO; Yonamine M; Crevelin EJ; Queiroz ME; Cecílio Hallak JE; Dos Santos RG
    Front Psychiatry; 2021; 12():688439. PubMed ID: 34421675
    [No Abstract]   [Full Text] [Related]  

  • 16. Subacute effects of the psychedelic ayahuasca on the salience and default mode networks.
    Pasquini L; Palhano-Fontes F; Araujo DB
    J Psychopharmacol; 2020 Jun; 34(6):623-635. PubMed ID: 32255395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.
    Kuypers KP; Riba J; de la Fuente Revenga M; Barker S; Theunissen EL; Ramaekers JG
    Psychopharmacology (Berl); 2016 Sep; 233(18):3395-403. PubMed ID: 27435062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.
    Riba J; Anderer P; Jané F; Saletu B; Barbanoj MJ
    Neuropsychobiology; 2004; 50(1):89-101. PubMed ID: 15179026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users.
    Bouso JC; Fábregas JM; Antonijoan RM; Rodríguez-Fornells A; Riba J
    Psychopharmacology (Berl); 2013 Dec; 230(3):415-24. PubMed ID: 23793226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016-2020) systematic review of preclinical and human studies.
    Rodrigues LS; Rossi GN; Rocha JM; L Osório F; Bouso JC; Hallak JEC; Dos Santos RG
    Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):541-556. PubMed ID: 33914164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.